IART Integra LifeSciences Holdings Corp Forecast, Technical & Fundamental Analysis
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications... Show more
IART is expected to report earnings to fall 10.43% to 48 cents per share on July 29
Q2'26
Est.
$0.48
Q1'26
Beat
by $0.14
Q4'25
Beat
by $0.03
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.01
The last earnings report on May 05 showed earnings per share of 54 cents, beating the estimate of 40 cents. With 255.27K shares outstanding, the current market capitalization sits at 1.37B.
A.I. Advisor
published General Information
General Information
a manufacturer of medical devices, implants and biomaterials
A.I.dvisor indicates that over the last year, IART has been loosely correlated with CNMD. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IART jumps, then CNMD could also see price increases.
IART in +2.33% Uptrend, advancing for three consecutive days on June 22, 2026
Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where IART advanced for three days, in of 293 cases, the price rose further within the following month. The odds of a continued upward trend are .
Technical Analysis (Indicators)
Bullish Trend Analysis
The 50-day moving average for IART moved above the 200-day moving average on June 09, 2026. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.
The Aroon Indicator entered an Uptrend today. In of 159 cases where IART Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
Bearish Trend Analysis
The 10-day RSI Indicator for IART moved out of overbought territory on June 10, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 similar instances where the indicator moved out of overbought territory. In of the 21 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where IART's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for IART turned negative on June 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IART declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
IART broke above its upper Bollinger Band on June 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. IART’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.314) is normal, around the industry mean (10.753). P/E Ratio (66.483) is within average values for comparable stocks, (61.509). Projected Growth (PEG Ratio) (0.669) is also within normal values, averaging (3.702). IART has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.018). P/S Ratio (0.822) is also within normal values, averaging (23.786).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IART’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
